Last updated on December 2018

A Registry for Patients Taking Uptravi

Brief description of study

This is a US multi-center, prospective, real world, observational drug registry enrolling patients actively treated with Uptravi. Participating patients will be followed prospectively for a maximum of 18 months from the date of enrollment into the registry.

Clinical Study Identifier: NCT03278002

Find a site near you

Start Over

University of Virginia System

Charlottesville, VA United States
  Connect »